VC Roundup: Relay Raises $57m To Seek Drug Targets Among Proteins In Motion

14 Sep 2016

Relay launched with $57m to develop its novel technology platform for drug discovery based on protein motion with an initial focus on therapies for genetically defined cancers.

Alexis Borisy Relay Therapeutics — Relay Executive Chairman and Interim CEO Alexis Borisy • Source: Relay Therapeutics

VC Roundup: Relay Raises $57m To Seek Drug Targets Among Proteins In Motion

More from Business

More from Scrip